Select a medication above to begin.
paricalcitol
generic
Adult Dosing .
Dosage forms: CAP: 1 mcg, 2 mcg, 4 mcg; INJ: various
hyperparathyroidism, secondary
- [CKD stage 3 not on dialysis, iPTH <500]
- Dose: individualize dose PO qd; Start: 1 mcg PO qd, then may adjust by 1 mcg/day q2-4wk; Alt: start 2 mcg PO 3x/wk, then may adjust by 2 mcg/dose q2-4wk; Info: routine use not recommended, refer to KDIGO guidelines; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; for 3x/wk dosing, dose no more frequently than qod
- [CKD stage 3 not on dialysis, iPTH >500]
- Dose: individualize dose PO qd; Start: 2 mcg PO qd, then may adjust by 1 mcg/day q2-4wk; Alt: start 4 mcg PO 3x/wk, then may adjust by 2 mcg/dose q2-4wk; Info: routine use not recommended, refer to KDIGO guidelines; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; for 3x/wk dosing, dose no more frequently than qod
- [CKD stage 4 or 5 not on dialysis, iPTH <500]
- Dose: individualize dose PO qd; Start: 1 mcg PO qd, then may adjust by 1 mcg/day q2-4wk; Alt: start 2 mcg PO 3x/wk, then may adjust by 2 mcg/dose q2-4wk; Info: for pts w/ severe or progressive hyperparathyroidism; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; for 3x/wk dosing, dose no more frequently than qod
- [CKD stage 4 or 5 not on dialysis, iPTH >500]
- Dose: individualize dose PO qd; Start: 2 mcg PO qd, then may adjust by 1 mcg/day q2-4wk; Alt: start 4 mcg PO 3x/wk, then may adjust by 2 mcg/dose q2-4wk; Info: for pts w/ severe or progressive hyperparathyroidism; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; for 3x/wk dosing, dose no more frequently than qod
- [CKD stage 5 on dialysis, PO route]
- Dose: individualize dose PO 3x/wk; Start: 3x/wk PO dose of baseline iPTH levels divided by 80; Info: adjust dose based on iPTH, Ca, PO4 levels; dose no more frequently than qod
- [CKD stage 5 on dialysis, IV route]
- Dose: individualize dose IV 3x/wk; Start: 0.04-0.1 mcg/kg/dose IV 3x/wk, then may adjust by 2-4 mcg/dose q2-4wk; Max: 0.24 mcg/kg/day; Info: see pkg insert for dose adjustments based on iPTH, Ca levels; dose no more frequently than qod
renal dosing
- [see below]
- CKD stage 3-5: no adjustment; Info: not defined if CKD stage 2
- HD/PD: no adjustment; no supplement
hepatic dosing
- [see below]
- mild-moderate impairment: no adjustment; severe impairment: not defined
Peds Dosing .
- Dosage forms: CAP: 1 mcg, 2 mcg, 4 mcg; INJ: various
hyperparathyroidism, secondary
- [CKD stage 3 not on dialysis, 10-16 yo]
- Dose: individualize dose PO 3x/wk; Start: 1 mcg PO 3x/wk, then may incr. by 1 mcg/dose q4wk; Info: routine use not recommended, refer to KDIGO guidelines; may decr. by 1 mcg/dose at any time; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; dose no more frequently than qod
- [CKD stage 3 not on dialysis, 17 yo and older, iPTH <500]
- Dose: individualize dose PO qd; Start: 1 mcg PO qd, then may adjust by 1 mcg/day q2-4wk; Alt: start 2 mcg PO 3x/wk, then may adjust by 2 mcg/dose q2-4wk; Info: routine use not recommended, refer to KDIGO guidelines; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; for 3x/wk dosing, dose no more frequently than qod
- [CKD stage 3 not on dialysis, 17 yo and older, iPTH >500]
- Dose: individualize dose PO qd; Start: 2 mcg PO qd, then may adjust by 1 mcg/day q2-4wk; Alt: start 4 mcg PO 3x/wk, then may adjust by 2 mcg/dose q2-4wk; Info: routine use not recommended, refer to KDIGO guidelines; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; for 3x/wk dosing, dose no more frequently than qod
- [CKD stage 4 or 5 not on dialysis, 10-16 yo]
- Dose: individualize dose PO 3x/wk; Start: 1 mcg PO 3x/wk, then may incr. by 1 mcg/dose q4wk; Info: for pts w/ severe or progressive hyperparathyroidism; may decr. by 1 mcg/dose at any time; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; dose no more frequently than qod
- [CKD stage 4 or 5 not on dialysis, 17 yo and older, iPTH <500]
- Dose: individualize dose PO qd; Start: 1 mcg PO qd, then may adjust by 1 mcg/day q2-4wk; Alt: start 2 mcg PO 3x/wk, then may adjust by 2 mcg/dose q2-4wk; Info: for pts w/ severe or progressive hyperparathyroidism; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; for 3x/wk dosing, dose no more frequently than qod
- [CKD stage 4 or 5 not on dialysis, 17 yo and older, iPTH >500]
- Dose: individualize dose PO qd; Start: 2 mcg PO qd, then may adjust by 1 mcg/day q2-4wk; Alt: start 4 mcg PO 3x/wk, then may adjust by 2 mcg/dose q2-4wk; Info: for pts w/ severe or progressive hyperparathyroidism; see pkg insert for dose adjustments based on iPTH, Ca, PO4 levels; for 3x/wk dosing, dose no more frequently than qod
- [CKD stage 5 on dialysis, PO route, 10-16 yo]
- Dose: individualize dose PO 3x/wk; Start: 3x/wk PO dose of baseline iPTH levels divided by 120, then may incr. by 1 mcg/day q4wk; Info: may decr. dose by 2 mcg/dose at any time; adjust dose based on iPTH, Ca, PO4 levels; dose no more frequently than qod
- [CKD stage 5 on dialysis, PO route, 17 yo and older]
- Dose: individualize dose PO 3x/wk; Start: 3x/wk PO dose of baseline iPTH levels divided by 80; Info: adjust dose based on iPTH, Ca, PO4 levels; dose no more frequently than qod
- [CKD stage 5 on dialysis, IV route, 5 yo and older]
- Dose: individualize dose IV 3x/wk; Start: 0.04 mcg/kg/dose IV 3x/wk if baseline iPTH <500 or 0.08 mcg/kg/dose IV 3x/wk if baseline iPTH >500; Info: see pkg insert for dose adjustments based on iPTH, Ca levels; dose no more frequently than qod
renal dosing
- [see below]
- CKD stage 3-5: no adjustment; Info: not defined if CKD stage 2
- HD/PD: no adjustment; no supplement
hepatic dosing
- [see below]
- mild-moderate impairment: no adjustment; severe impairment: not defined